Selected article for: "alanine aminotransferase and AST aspartate aminotransferase"
Author: Yueping Li; Zhiwei Xie; Weiyin Lin; Weiping Cai; Chunyan Wen; Yujuan Guan; Xiaoneng Mo; Jian Wang; Yaping Wang; Ping Peng; Xudan Chen; Wenxin Hong; Guangming Xiao; Jinxin Liu; Lieguang Zhang; Fengyu Hu; Feng Li; Feng Li; Fuchun Zhang; Xilong Deng; Linghua Li
Title: An exploratory randomized, controlled study on the efficacy and safety of lopinavir/ritonavir or arbidol treating adult patients hospitalized with mild/moderate COVID-19 (ELACOI)
  • Document date: 2020_3_23
    • ID: 9hknw4ws_15
    Snippet: All participants met the following inclusion criteria: 1) age between 18 and 80 years; 2) SARS-CoV-2 infection confirmed by real-time PCR (RT-PCR) from pharyngeal swab; 3) mild clinical status, defined as having mild clinical symptoms but no signs of pneumonia on imaging or moderate clinical status, defined as having fever, respiratory symptoms and pneumonia on imaging [5]; 4) the following lab findings: creatinine ≤ 110μmol/L, creatinine clea.....
    Document: All participants met the following inclusion criteria: 1) age between 18 and 80 years; 2) SARS-CoV-2 infection confirmed by real-time PCR (RT-PCR) from pharyngeal swab; 3) mild clinical status, defined as having mild clinical symptoms but no signs of pneumonia on imaging or moderate clinical status, defined as having fever, respiratory symptoms and pneumonia on imaging [5]; 4) the following lab findings: creatinine ≤ 110μmol/L, creatinine clearance rate (eGFR) ≥ 60 ml/min/1.73m 2 , aspartate aminotransferase (AST) and alanine aminotransferase (ALT) ≤ 5 × ULN, and total bilirubin (TBIL) ≤ 2 × ULN; 5) willingness to participate in the study and provide informed consent. Patients All rights reserved. No reuse allowed without permission. author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

    Search related documents:
    Co phrase search for related documents
    • alanine aminotransferase and aspartate aminotransferase: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • alanine aminotransferase and clinical status: 1, 2, 3
    • alanine aminotransferase and creatinine clearance: 1, 2
    • alanine aminotransferase and inclusion criterion: 1
    • alanine aminotransferase and informed consent: 1, 2
    • ALT alanine aminotransferase and aspartate aminotransferase: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • ALT alanine aminotransferase and clinical status: 1
    • ALT alanine aminotransferase and creatinine clearance: 1
    • ALT alanine aminotransferase and informed consent: 1
    • aspartate aminotransferase and clinical status: 1
    • aspartate aminotransferase and creatinine clearance: 1, 2, 3
    • aspartate aminotransferase and inclusion criterion: 1
    • aspartate aminotransferase and informed consent: 1, 2
    • clinical status and informed consent: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18
    • clinical status and informed consent provide: 1, 2
    • clinical status and mild clinical status: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • clinical status and moderate clinical status: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
    • clinical symptom and creatinine clearance: 1
    • clinical symptom and informed consent: 1, 2, 3, 4, 5